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Abstract
Background: To warrant the adoption or rejection of health care interventions in daily practice, it is
important to establish the point at which the available evidence is considered sufficiently conclusive. This
process must avoid bias resulting from multiple testing and take account of heterogeneity across studies.
The present paper addresses the issue of whether the available evidence may be considered sufficiently
conclusive to continue or discontinue the current practice of postoperative abdominal drainage after
pancreatic resection.
Methods: A systematic review was conducted of randomized and non-randomized studies comparing
outcomes after routine intra-abdominal drainage with those after no drainage after pancreatic resection.
Studies were retrieved from the PubMed, Cochrane Central Trial Register and EMBASE databases and
meta-analysed cumulatively, adjusting for multiple testing and heterogeneity using the iterated logarithm
method.
Results: Three reports, describing, respectively, one randomized and two non-randomized studies with
a comparative design, met the inclusion criteria predefined for primary studies reporting on drain
management and complications after pancreatic resection. These studies included 89, 179 and 226
patients, respectively. The absolute differences in rates of postoperative complications in these studies
were -6.4%, -9.5% and -6.3%, respectively, in favour of the no-drain groups. The cumulative risk
difference in major complications, adjusted for multiple testing and heterogeneity, was -7.8%, with a 95%
confidence interval of -20.2% to 4.7% (P = 0.214).
Conclusions: The routine use of abdominal drains after pancreatic resection may result in a higher risk
for major complications, but the evidence is inconclusive.
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Introduction
For several decades, the routine use of postoperative abdominal
drains has been standard practice in abdominal surgery. The
main rationale for this practice is the prevention of fluid collec-
tions in the abdomen and the detection of postoperative bleeding
or anastomotic leakage.1 However, the routine use of postopera-
tive drains in abdominal surgery can itself provoke complica-
tions. These include haemorrhage, inflammation, retrograde
bacterial migration, drain occlusion or loss, pain, and loss of
fluids and electrolytes.2 All such complications may delay recov-
ery and prolong hospital stay. The standard use of drains is also
interfering with attempts to accelerate recovery through
enhanced recovery after surgery (ERAS) programmes.3,4 There-
fore, it is no longer self-evident that the benefits of the routine
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use of postoperative drains after abdominal surgery outweigh the
associated risks.
Pancreatic resection may represent a special case in this respect
because a postoperative leakage of the pancreaticojejunostomy is
generally considered to pose an extra risk to the patient’s recovery
and health as a result of the autolytic properties of pancreatic
juices.5 However, as long ago as 1992, Jeekel questioned the
routine use of postoperative drainage after pancreatic resection.6
Since then, several randomized and non-randomized studies have
addressed the subject.
As evidence on the safety and effectiveness of health care
interventions accrues over time, a crucially important challenge
is to decide when the evidence that has amassed on the benefit
or harm of an intervention is clinically and statistically sufficient
to warrant its adoption or rejection in clinical practice. For this
purpose, the method of cumulative meta-analysis has been
developed.7,8 In the present study, this method was used to assess
whether there is currently sufficient evidence to omit post-
operative drainage after pancreatic resection without undue
complications.
Materials and methods
Literature search
A search of the PubMed, EMBASE and Cochrane Central Trial
Register databases was performed to identify studies on routine
peripancreatic drainage after pancreaticoduodenectomy (PD).
Search terms included ‘drainage’, ‘drain*’, ‘suction’, ‘pancre-
atectomy’, ‘pancreatic resection’, ‘pancreaticoduodenectomy’,
‘pancreat*’, ‘postoperative complications’, ‘complication*’, ‘fistula’
and ‘abscess’. The full search strategy is shown in Appendix S1
(online).
Study selection and data extraction
Eligible studies were assessed on predefined inclusion criteria. In
order to be considered as eligible, studies were required to: (i)
report primary data; (ii) include a study population consisting of
patients with suspected or histologically proven pancreatic or
periampullary malignancy; (iii) include a population of patients
undergoing pancreatic resection, including PD or distal resection,
and (iv) compare routine peripancreatic postoperative drainage
with no drainage. To make optimal use of the available evidence,
randomized as well as non-randomized studies, conducted pro-
spectively as well as retrospectively, were included taking into
account any heterogeneity in the analysis.
Two reviewers independently assessed all titles and abstracts for
inclusion. Disagreements were resolved by discussion. Full texts of
studies eligible for inclusion were retrieved. The following data
were extracted from the included studies: study design; inclusion
and exclusion criteria; population size; baseline characteristics;
duration of follow-up; statistical analysis; details of surgery and
postoperative care, and outcome data. Themethodological quality
of studies was assessed using the MINORS (methodological index
for non-randomized studies) score.9 This score has been found to
be a valid and reliable measure of the methodological quality of
surgical trials and can be used for both randomized and non-
randomized studies. It rates the appropriateness of enrolment of
patients, endpoints and their mode of assessment, follow-up,
control group, and statistical analysis, as well as comparability at
baseline.
Cumulative meta-analysis
The primary outcome of this analysis was risk for major postop-
erative complications. Major complications were defined as post-
operative complications severe enough to result in radiologic,
endoscopic or surgical intervention. Secondary outcome param-
eters were mortality rate and hospital length of stay (LoS). When
necessary, authors were contacted and asked to provide details on
the definition of endpoints. Quantitative data were entered into a
database using the statistical software package StatsDirect.10 For
each study included, a 2 ¥ 2 table was constructed to show the
number of events (major complications) and non-events in the
treatment (drain) and control (no-drain) groups. Risk differences
and associated cumulative Z-scores were calculated, both unad-
justed and adjusted, using the iterated logarithm method
described by Hu et al.11 A random-effects model was used, with
total variance consisting of within- and between-study variance.
To control for type I error, an adjustment factor (l) of 1.5 was
used, as recommended by Hu et al.11
Results
Studies included and their characteristics
The search produced 206 hits in PubMed (1969 to August 2011).
The 21 and 55 publications retrieved from the Cochrane Trial
Register and EMBASE, respectively, did not identify further eligi-
ble studies (Fig. 1). Three studies including a total of 494 patients
met the predefined selection criteria.12–14 Characteristics of these
studies are summarized in Table 1.
The study by Heslin et al.14 was a retrospective review of records
of patients who underwent PD, with only little variation in
surgery, including Roux-en-Y reconstruction and pylorus-
preserving procedures. Patients in the drain group routinely
received peripancreatic closed suction drains postoperatively. A
total of 38 patients were not given drains; in 51 patients, closed
suction drains were placed at the end of the procedure. Over 80%
of the patients included had malignant disease. On histologic
diagnosis, adenocarcinoma was found to be most prevalent. Loca-
tions of the tumour were the pancreas head (74%), ampulla of
Vater (13%), duodenum (5%) and distal common bile duct
(10%). Major complications were defined as death, reoperation,
significant pancreatic leak, fascial dehiscence, re-intubation,
pneumonia and intra-abdominal abscess. Major complications
occurred in 27% [95% confidence interval (CI) 16–42%] of the
drain group and 21% (95% CI 10–37%) of the no-drain group.
Mean LoS was 12 days in both groups. Outcome measures are
summarized in Table 2.
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The study by Conlon et al.12 was a randomized controlled trial
(RCT). It included a total of 179 patients with peripancreatic
tumours who were considered for surgical treatment and rand-
omized to receive no drain (n = 91) or a closed suction drain
(n = 88) placed at the end of the procedure. A total of 78% of the
procedures were PDs and 22% were distal pancreatectomies
(DPs). Because the authors did not classify the severity of com-
plications, complications requiring interventional radiologic pro-
Potentially relevant studies identified
and screened for retrieval
n = 206 
Studies retrieved for more detailed
evaluation
n = 32
Studies excluded based on title or
  abstract n = 174
Reasons
Not subject n = 79
Different type of surgery n = 19
Not primary n = 19
Case report n = 4
No malignancy n = 53
Studies included in the meta-analysis
n = 3
Studies excluded based on full-text
  screening n = 29
Reasons
Not subject n = 6
Not comparative n = 9
Different drain technique n = 12
No primary data n = 2
Figure 1 Flowchart showing the numbers of studies retrieved from the literature databases and the selection of studies according to
inclusion and exclusion criteria
Table 1 Summary of key characteristics of the included studies
Characteristics Heslin et al. 199814 Conlon et al. 200112 Fisher et al. 201113
Country; time period
when study was
conducted
USA; 1994–1996 USA; time period when study
was conducted not
reported
USA; 2004–2009 (drain group) and
2009–2010 (no-drain group)
Design of study Retrospective record review Randomized controlled trial
with two parallel groups
Prospective recording of data that
were retrospectively reviewed
Patient population PD for presumed or histologically proven
periampullary malignancy
Adult, peripancreatic tumour,
considered for surgical
resection
Consecutive patients undergoing
pancreatic resection
Type of surgery PD/PPPD (n = 89) PD (n = 133), PPPD (n = 6),
DP (n = 40)
PD (n = 153), DP (n = 73)
Drain versus no
drain, patients, n
51 versus 38 88 versus 91 179 versus 47
Follow-up period Not reported 3 months 30 days
Primary and
secondary
endpoints
Postoperative complications; OR
characteristics (duration of surgery, time
in OR, blood loss, need for blood
transfusion); pathology (presence of
malignancy, presence of nodal
metastasis, presence of positive margin)
Incidence of postoperative
complications; mortality,
re-intervention, hospital
stay
Anastomotic failure, percutaneous
abdominal drainage, delayed gastric
emptying, infectious complications
and organ failure, cardiovascular
complications, length of stay,
operative mortality.
Patient age, years,
drain versus
no-drain group
65  2 versus 65  2 (mean  SEM) 69 (33–87) versus 66 (23–81)
(median, range)
63 (53–72) versus 59 (51–70) (median,
interquartile range)
MINORS score 12/24 16/24 15/24
PD, pancreaticoduodenetomy; PPPD, pylorus-preserving pancreaticoduodenetomy; DP, distal pancreatectomy; OR, operating room; SEM, standard
error of the mean.
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cedures or a return to the operating room were rated as major
complications. Such complications were reported in 22% (95%CI
14–32%) of patients in the drain group and 12% (95% CI 6–21%)
of those in the no-drain group. Mortality within 30 days after
surgery was 2% in both groups. Hospital LoS did not differ
between the two groups; overall median LoS was 9 days (range:
5–11 days). Twenty-nine patients were readmitted to hospital. Of
these readmissions, 19 occurred in the drain group and 10 in the
no-drain group (P = 0.07). The median duration of readmission
was significantly longer in the patients in the drain group (10 days
versus 5 days; P < 0.05).
Fisher et al.13 prospectively collected data for a total of 226
patients including 179 in whom postoperative drains were rou-
tinely placed after pancreatic resection (2004–2009) and 47 in
whom no postoperative drains were placed after pancreatic resec-
tion (2009–2010). In this study, the Common Terminology Crite-
ria for Adverse Events (CTCAE) index15 was used to record
complications; events of grade 3 or greater were considered as
major complications.Major complications occurred in 21% (95%
CI 15–28%) of patients in the drain group and 15% (95% CI
6–28%) of patients without drains (P = 0.3). No differences in
median hospital stay (7 days) were observed between the two
cohorts. The readmission rate was significantly higher in the
no-drain cohort (17% versus 9%; P = 0.007). Of eight patients in
the no-drain cohort who required readmission, five underwent
percutaneous drainage for pancreatic fistula and the other three
required observation only.
Cumulative meta-analysis
The results of themeta-analysis are presented in Table 3 and Figs 2
and 3. The proportions of patients with major postoperative com-
plications were consistently lower in the no-drain groups com-
pared with the drain groups. The differences in risk for major
complications in the three studies12–14 were -6.4% (95% CI
-33.9% to 21.1%), -9.5% (95% CI -24.2% to 6.9%) and -6.3%
(95% CI -20.2% to 4.7%), respectively. However, in none of the
studies did this difference reach statistical significance. The unad-
justed cumulative Z-score of the three studies12–14 was -2.13, just
Table 2 Summary of outcomes of included studies. Numbers represent proportions and 95% confidence intervals, unless stated otherwise
Outcomes, no-drain
versus drain
Heslin et al. 199814 Conlon et al. 200112 Fisher et al. 201113
Operative mortality Not reported 2% (0–8) versus 2% (0–8) 2% (0–11) versus 1% (0–3)
Major complications 21% (10–37) versus 27% (16–42)a 12% (6–21) versus 22% (14–32)b 15% (6–28) versus 21% (15–28)c
Minor complications 24% (11–40) versus 25% (14–40) Not reported as separate category 11% (4–23) versus 8% (4–13)d
Fistula 3% (0–14) versus 6% (1–16) 0% (0–4) versus 17% (10–27)e 11% (4–23) versus 12% (7–17)f
Intra-abdominal abscess 0% (0–9) versus 6% (1–16) 7% (2–14) versus 7% (3–14) 4% (1–15) versus 6% (3–10)
Intra-abdominal collection Not reported 2% (0–8) versus 7% (3–14) Not reported
Reoperation 8% (2–21) versus 2% (0–10) 4% (1–11) versus 9% (4–17) 0% (0–8) versus 4% (2–9)
CT-guided drainage 3% (0–14) versus 4% (0–14) 8% (3–15) versus 13% (6–21) 11% (4–23) versus 2% (1–6)
Length of hospital stay, days 12  1 versus 12  1 (mean) 9 versus 9 (median) 7 (6–8) versus 7 (7–10) (median, quintiles)
Readmission Not reported Not reported 17% (8–31) versus 9% (6–15)
aDefinition of major complication: death, reoperation, significant leak/fistula, fascial dehiscence, re-intubation, pneumonia, intra-abdominal abscess,
myocardial infarction, pulmonary embolus, cerebrovascular accident, multisystem organ failure (Heslin MJ, personal communication, 2011).
bComplications requiring return to operating room or interventional radiology.
cGrade 3 or higher, Common Terminology Criteria for Adverse Events (CTCAE) classification.
dGrade 1 or 2, CTCAE classification.
eIncludes enterocutaneous fistula and pancreatic fistula.
fClinically significant, Grade B or C, International Study Group on Pancreatic Fistula classification.
CT, computed tomography.
Table 3 Difference in risk for major postoperative complications between patients with and without the routine placement of postoperative
drains after pancreatic resection, using individual Z-statistics and cumulative Z-statistics, unadjusted and adjusted for multiple testing and
heterogeneity across studies
Study Risk difference, % Z-statistic for each
individual study
Cumulative Z-statistic,
unadjusted
Cumulative Z-statistic
adjusted (LIL-based)
(random-effects model)
Heslin et al. 199814 -6.4 -0.703 -0.703 -0.653
Conlon et al. 200112 -9.5 -1.709 -1.889 -1.180
Fisher et al. 201113 -6.3 -1.051 -2.128 -1.240
LIL, law of iterated logarithm.
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crossing the critical value of -1.96, which suggests that statistical
significance was reached when the data from the study by Fisher
et al.13 were combined with the data from the previous two stud-
ies.12,14 However, after adjustment for multiple testing and hetero-
geneity using the iterated logarithm method, the cumulative
Z-score was -1.24, indicating that the difference had not reached
statistical significance. The adjusted cumulative difference in risk
for major complications for the three studies12–14 was -7.8%, with
a 95% CI of -20.2% (favouring no drainage) to 4.7% (favouring
drainage).
Meta-analysis of the secondary endpoints (mortality and LoS)
proved to be impossible because the requisite data on variance
could not be extracted from the original studies12–14 nor obtained
from the authors.
Discussion
There is a persuasive logic to the practice of routine drainage after
pancreatic surgery because drainage is assumed to allow for the
early identification and monitoring of fluid collections and sub-
sequently to prevent their negative impact on the patient’s recov-
ery. It seems, however, that the available evidence does not support
this practice. In this study, a traditional meta-analysis of the avail-
able evidence pointed to a significantly lower complication rate in
Heslin et al.14
Heslin et al.14, Conlon et al.12
Heslin et al.14, Conlon et al.12, Fisher et al.13
–0.5 –0.4 –0.3 –0.2 –0.1 0.0 0.1
Risk difference
0.2 0.3 0.4 0.5
Figure 2 Cumulative random-effects meta-analysis using the law of iterated logarithm of three studies of routine postoperative drainage after
pancreatic resection, showing risk differences and 95% confidence intervals
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Figure 3 Cumulative meta-analysis of outcomes of routine postoperative drainage after pancreatic resection showing cumulative Z-statistics
for the effect of omitting drainage on the occurrence of major postoperative complications. Traditional cumulative Z-statistics and
Z-statistics are adjusted for multiple testing and heterogeneity. LIL, law of iterated logarithm
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the group without routine drainage. However, when a cumulative
meta-analysis was performed with adjustment for repeated testing
and heterogeneity, this difference was no longer statistically
significant.
It is important to establish when the available evidence may be
considered sufficiently conclusive to warrant the use of a particu-
lar intervention in daily practice. In this process, care should be
taken to avoid bias resulting from multiple testing and heteroge-
neity across studies should be taken into account. Several methods
have been developed to address this issue. Pogue and Yusuf16 pro-
posed the alpha-spending approach for controlling type I error in
cumulative meta-analysis. However, this approach is a closed
sequential process, requiring the pre-specification of the final
sample size, which is usually unknown.11 The approach used in
this study was recently developed by Hu et al.11
The method proposed by Hu et al.11 accounts for multiple
testing and for heterogeneity across studies in a cumulative meta-
analysis of trials with a binary endpoint. This method typically
involves the performance of an updated meta-analysis every time
that new evidence becomes available. Two challenges are encoun-
tered when using this method. Firstly, the procedure suffers from
the problem of repeated testing and the associated inflated overall
type I error (the unjustified acceptance of evidence of benefit or
harm).17 Secondly, because data may be pooled from studies that
are spread over a prolonged period of time, medical technology,
supportive care and patient populations may differ across studies,
introducing substantial heterogeneity. The method, based on the
law of Z-statistics, is an open and therefore more flexible approach
towards controlling for type I error compared with those men-
tioned earlier. Moreover, it allows for reliable estimation of the
between-study variance component, which is challenging, espe-
cially in a context in which the number of studies is small.11
In the studies12–14 included in the present analysis, substantial
heterogeneity was found. This related to research design, defini-
tions of endpoints, patient populations, types of interventions and
supportive care. In particular, the definition of what constitutes a
major complication differed among the studies, none of which
used a standardized scale such as the Clavien–Dindo system of
classification. An attempt was made to pool the different results as
adequately as possible by comparing the different scoring systems.
Such heterogeneity is likely to represent the rule rather than the
exception, and therefore should be taken into account in any
analysis in which studies are combined to make optimal use of the
available evidence.
With respect to postoperative drains, several studies on other
types of surgery, such as colon and liver surgery, have shown that
the use of abdominal drains is not beneficial in terms of postop-
erative outcome and may even be harmful.18 Pancreaticoduo-
denectomy is technically one of the most challenging surgical
procedures and is associated with potential anastomotic break-
down attributable to the activity of pancreatic enzymes; probably
in response to this, surgeons tend to favour the conventional
placement of abdominal drains. In order to avoid the risk for
retrograde infection but to preserve the diagnostic safety drains
are alleged to provide, some surgeons choose to place drains after
every pancreatic resection and remove them after a short period of
time. Kawai et al.19 assessed 104 consecutive patients undergoing
pancreatic head resection and came to the conclusion that remov-
ing the drain on postoperative day 4 rather than day 8 reduced the
incidence of complications. A soft pancreas is thought to result in
a higher incidence of complications and therefore Kawai et al.19
also evaluated the impact of this clinical variable; however, the
difference between groups in postoperative complication rates
was not statistically significant. Bassi et al.20 assessed 114 patients
with a low prior probability of pancreatic fistula, including only
patients with drain amylase levels of 5000 U/l. They concluded
that the drain could safely be removed on postoperative day 3.
Moreover, delayed removal of the drains (after postoperative day
5) led to a higher complication rate and increased hospital LoS
and costs. Therefore, if abdominal drains are placed, it seems that
their removal within a short period of time is justified.
It is important to note that two12,14 of the three studies12–14
included in this review included patients undergoing DP as well as
those scheduled for PD among their study samples (113 of 494
patients, 22%). Heslin et al.14 did not report the exact numbers of
patients undergoing each type of resection. In the study by
Conlon et al.12 patients in the DP group were more likely to be
allocated to the no-drain group than those in the PD group (DP
group: drain group, n = 15 versus no-drain group, n = 25; PD
group, drain group, n = 73 versus no-drain group, n = 66). In the
study by Fisher et al.,13 both PD and DP patients were equally
divided between the drain and no-drain groups. Nonetheless,
this potentially increases complication rates and makes adequate
comparison more difficult because leak rates after DP have been
reported to be 22%, whereas leak rates after PD have been
reported to be 11%.21,22
The reluctance of surgeons to abandon abdominal drainage is
understandable given the well-known detrimental effects of
leakage of the pancreatojejunostomy and the absence of suffi-
ciently powered,high-level evidence onprophylactic drainage after
pancreatic resection. However, the development of less invasive
radiologic intervention techniques benefits the treatment of post-
operative complications such as intra-abdominal abscesses.23 This
may contribute to a reduction in surgeon anxiety in relation to the
development of severe complications and eventually to thewilling-
ness to abandon abdominal drainage after pancreatic resection.
A recently published overview of the available evidence for the
use of abdominal drains after pancreatic resection adopted a
slightly different approach, using a standard Mantel–Haenszel
random-effects model and separate evaluations of overall and
specific complications, respectively.24 It was concluded that more
evidence is required before any firm conclusions on the use of
abdominal drains can be reached, which is in line with the present
findings. This overview24 also included studies comparing the early
and late removal of abdominal drains, which resulted in the inclu-
sion of a higher number of studies. However, the study by Fisher
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et al.13 had not been published at the time this earlier analysis24 was
conducted and as a consequence its results were not included in the
analysis.Moreover,Diener et al.24 did not correct for heterogeneity
and multiple testing and thus their results should be interpreted
with great caution. Unfortunately, studies suitable for meta-
analysis remain scarce and this affects the results of the present
study to a similar extent as it has previousmeta-analyses.Moreover,
two of the studies12,14 included in the present analysis were con-
ducted at the same centre in different timeframes, which may have
introduced bias to the present study. Nonetheless, both of these
studies (randomized andnon-randomized)were included in order
to facilitate the pooling of data for as many patients as possible. In
addition, in the current analysis,MINORS scores were used to rate
the studies for quality. These scores provided evidence that the
non-randomized studies included in the present analysis were of
sufficient quality. It is of interest that the results of the non-
randomized studies do not differ substantially from those of the
RCT, which suggests that non-randomization did not introduce
significant bias in the case of these two studies.
In conclusion, the current study shows the importance of
taking into account multiple testing and heterogeneity within
and between studies when conducting a meta-analysis. Without
adjustment for the latter, the currently available evidence might be
taken to imply that omitting drainage after pancreatic surgery
leads to a statistically significant decrease in the risk for major
complications. However, that conclusion is premature, as can be
inferred from the present results when multiple testing and het-
erogeneity are taken into account. At present, an international,
multicentre RCT intended to establish whether or not the prophy-
lactic use of abdominal drains after PD can be abandoned is in
preparation in the Netherlands. Until the results of such a trial
become available, drain policy will depend on the surgeon’s judge-
ment. The available evidence suggests that it is reasonable to adopt
a no-drain policy because not using a drain does not seem to
increase postoperative complications.
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